Cortexyme Inc. (CRTX) NASDAQ
$1.95 0.05 (2.63%)
Market Cap: $58.79M
As of 07/29/22 04:00 PM EDT. Market closed.
Cortexyme Inc. (CRTX) NASDAQ
$1.95 0.05 (2.63%)
Market Cap: $58.79M
As of 07/29/22 04:00 PM EDT. Market closed.
Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2/3 clinical trial in ... read more
Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2/3 clinical trial in patients with mild to moderate Alzheimer's disease. Cortexyme is targeting a specific, infectious pathogen found in the brain and other organs and tied to degeneration and inflammation in humans and animal models. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$277,019
CEO Compensation (Total)
$917,333
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$277,019
CEO Compensation (Total)
$917,333
URL
Address
.
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$1.88
Previous Close
$1.90
Days Range
$1.86 - $1.97
52 week range
$1.78 - $121.98
Volume
0
Avg. Volume (30 days)
289,916
Market Cap
$58.79M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,150,835
Open
$1.88
Previous Close
$1.90
Days Range
$1.86 - $1.97
52 week range
$1.78 - $121.98
Volume
0
Avg. Volume (30 days)
289,916
Market Cap
$58.79M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
30,150,835
Open in:
Open in:
INSIDER TRANSACTIONS FOR CORTEXYME INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Monohon Ted | Chief Accounting Officer & VP | Dec 05, 2022 | Option Exercise | $0.72 | 1,640 | 1,181 | 29,311 | Dec 07, 2022, 05:37 PM |
| Monohon Ted | Chief Accounting Officer & VP | Sep 06, 2022 | Option Exercise | $1.64 | 1,520 | 2,493 | 30,951 | Sep 08, 2022, 05:58 PM |
| Monohon Ted | Chief Accounting Officer & VP | Jun 06, 2022 | Option Exercise | $3.12 | 1,529 | 4,770 | 32,471 | Jun 08, 2022, 04:13 PM |
| Holsinger Leslie | EVP, Preclinical Development | Jun 06, 2022 | Option Exercise | $2.86 | 10,920 | 31,231 | 148,080 | Jun 08, 2022, 04:10 PM |
| McDowell Caryn Gordon | Chief Legal & Adm. Officer | Jun 06, 2022 | Option Exercise | $2.86 | 6,700 | 19,183 | 133,300 | Jun 08, 2022, 04:09 PM |
| McDowell Caryn Gordon | Chief Legal & Adm. Officer | Jun 06, 2022 | Sale | $2.86 | 10,800 | 30,923 | 122,500 | Jun 08, 2022, 04:09 PM |
| Lynch Casey | Chief Executive Officer | Nov 18, 2021 | Option Exercise | $0.46 | 60,000 | 27,600 | 109,895 | Nov 19, 2021, 08:58 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Nov 16, 2021 | Option Exercise | $2.23 | 30,000 | 66,900 | 90,000 | Nov 16, 2021, 08:17 PM |
| Dominy Stephen S. | Chief Scientific Officer | Nov 12, 2021 | Buy | $14.40 | 763 | 10,987 | 1,217,086 | Nov 12, 2021, 06:47 PM |
| McLoughlin Margaret | Director | Oct 08, 2021 | Option Exercise | $17.00 | 1,000 | 17,000 | 1,000 | Oct 12, 2021, 05:48 PM |
| McLoughlin Margaret | Director | Oct 08, 2021 | Sale | $88.93 | 1,000 | 88,930 | 0 | Oct 12, 2021, 05:48 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Oct 05, 2021 | Option Exercise | $54.85 | 4,963 | 272,221 | 64,963 | Oct 07, 2021, 06:24 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Oct 05, 2021 | Sale | $98.50 | 4,963 | 488,856 | 60,000 | Oct 07, 2021, 06:24 PM |
| McLoughlin Margaret | Director | Aug 16, 2021 | Option Exercise | $17.00 | 6,000 | 102,000 | 6,000 | Aug 18, 2021, 05:30 PM |
| McLoughlin Margaret | Director | Aug 16, 2021 | Sale | $95.44 | 6,000 | 572,644 | 2,944 | Aug 18, 2021, 05:30 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Aug 17, 2021 | Option Exercise | $2.23 | 30,000 | 66,900 | 60,000 | Aug 18, 2021, 05:25 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Aug 16, 2021 | Option Exercise | $2.23 | 22,000 | 49,060 | 52,000 | Aug 18, 2021, 05:25 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Aug 16, 2021 | Sale | $95.31 | 22,000 | 2,096,779 | 42,842 | Aug 18, 2021, 05:25 PM |
| Detke Michael J. | Chief Medical Officer | Aug 10, 2021 | Option Exercise | $2.23 | 10,000 | 22,300 | 10,000 | Aug 12, 2021, 05:37 PM |
| Detke Michael J. | Chief Medical Officer | Aug 10, 2021 | Sale | $100.00 | 10,000 | 1,000,000 | 0 | Aug 12, 2021, 05:37 PM |
| Detke Michael J. | Chief Medical Officer | Jul 07, 2021 | Option Exercise | $2.23 | 17,400 | 38,802 | 17,400 | Jul 07, 2021, 08:38 PM |
| Detke Michael J. | Chief Medical Officer | Jul 06, 2021 | Option Exercise | $2.23 | 12,600 | 28,098 | 40,861 | Jul 07, 2021, 08:38 PM |
| Detke Michael J. | Chief Medical Officer | Jul 06, 2021 | Sale | $53.54 | 40,861 | 2,187,623 | 8,548 | Jul 07, 2021, 08:38 PM |
| Detke Michael J. | Chief Medical Officer | Jul 07, 2021 | Sale | $55.20 | 17,400 | 960,549 | 13,466 | Jul 07, 2021, 08:38 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Jun 30, 2021 | Option Exercise | $2.23 | 30,000 | 66,900 | 30,000 | Jun 30, 2021, 05:46 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Jun 28, 2021 | Option Exercise | $2.23 | 20,000 | 44,600 | 20,000 | Jun 30, 2021, 05:46 PM |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | Jun 28, 2021 | Sale | $54.15 | 20,000 | 1,083,074 | 12,276 | Jun 30, 2021, 05:46 PM |
| McLoughlin Margaret | Director | Jun 28, 2021 | Sale | $55.15 | 550 | 30,332 | 350 | Jun 29, 2021, 05:26 PM |
| Lamond David | Director | Mar 24, 2021 | Buy | $33.77 | 50,000 | 1,688,500 | 1,847,109 | Mar 24, 2021, 09:06 PM |
| Lynch Casey | Chief Executive Officer | Mar 22, 2021 | Sale | $35.59 | 30,000 | 1,067,611 | 1,027,563 | Mar 23, 2021, 07:06 PM |
| Lamond David | Director | Mar 04, 2021 | Buy | $35.34 | 50,000 | 1,767,057 | 1,797,109 | Mar 05, 2021, 05:54 PM |
| Lynch Casey | Chief Executive Officer | Feb 03, 2021 | Sale | $43.03 | 20,000 | 860,530 | 1,058,374 | Feb 03, 2021, 07:45 PM |
| Lynch Casey | Chief Executive Officer | Feb 02, 2021 | Sale | $36.21 | 20,000 | 724,102 | 1,063,845 | Feb 03, 2021, 07:45 PM |
| Lynch Casey | Chief Executive Officer | Feb 01, 2021 | Sale | $36.25 | 20,000 | 724,968 | 1,094,088 | Feb 03, 2021, 07:45 PM |
| Holsinger Leslie | Executive Vice President | Dec 14, 2020 | Option Exercise | $0.27 | 40,000 | 10,800 | 43,500 | Dec 15, 2020, 07:17 PM |
| Holsinger Leslie | Executive Vice President | Dec 14, 2020 | Sale | $30.81 | 40,000 | 1,232,528 | 41,800 | Dec 15, 2020, 07:17 PM |
| Holsinger Leslie | Executive Vice President | Dec 10, 2020 | Option Exercise | $0.27 | 3,500 | 945 | 3,500 | Dec 14, 2020, 05:16 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | Jun 12, 2020 | Buy | $44.06 | 2,440 | 107,506 | 2,860,967 | Jun 15, 2020, 06:55 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | Jun 11, 2020 | Buy | $44.32 | 6,600 | 292,512 | 2,858,527 | Jun 15, 2020, 06:55 PM |
| Lamond David | Director | Jun 04, 2020 | Buy | $43.27 | 49,125 | 2,125,795 | 1,747,109 | Jun 08, 2020, 06:47 PM |
| PFIZER INC | 10% Owner | Jun 03, 2020 | Sale | $40.18 | 370,000 | 14,866,600 | 2,879,973 | Jun 04, 2020, 04:25 PM |
| Detke Michael J. | Chief Medical Officer | May 27, 2020 | Option Exercise | $6.91 | 5,515 | 38,109 | 28,261 | May 29, 2020, 04:48 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | May 22, 2020 | Buy | $55.90 | 2,085 | 116,552 | 2,851,927 | May 22, 2020, 06:03 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | May 21, 2020 | Buy | $55.80 | 520 | 29,016 | 2,849,842 | May 22, 2020, 06:03 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | May 20, 2020 | Buy | $57.95 | 6,085 | 352,605 | 2,849,322 | May 22, 2020, 06:03 PM |
| Lamond David | Director | May 19, 2020 | Buy | $56.24 | 39,200 | 2,204,683 | 1,697,984 | May 19, 2020, 06:41 PM |
| Lamond David | Director | May 15, 2020 | Buy | $48.93 | 5,448 | 266,569 | 1,658,784 | May 19, 2020, 06:41 PM |
| Detke Michael J. | Chief Medical Officer | Apr 02, 2020 | Option Exercise | $6.91 | 5,515 | 38,109 | 22,746 | Apr 06, 2020, 05:39 PM |
| YOUNG KEVIN | Director | May 13, 2019 | Buy | $17.00 | 30,000 | 510,000 | 30,000 | Mar 12, 2020, 04:46 PM |
| RYAN UNA S | Director | May 13, 2019 | Buy | $17.00 | 2,875 | 48,875 | 2,875 | Mar 12, 2020, 04:43 PM |
| McLoughlin Margaret | Director | May 13, 2019 | Buy | $17.00 | 550 | 9,350 | 550 | Mar 12, 2020, 04:40 PM |
| Lamond David | Director | Feb 10, 2020 | Option Exercise | $50.00 | 30,000 | 1,500,000 | 1,653,336 | Feb 10, 2020, 06:18 PM |
| Detke Michael J. | Chief Medical Officer | Feb 07, 2020 | Option Exercise | $6.91 | 17,231 | 119,066 | 17,231 | Feb 10, 2020, 06:15 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | Jan 29, 2020 | Option Exercise | $54.30 | 4,338 | 235,553 | 2,843,237 | Jan 31, 2020, 01:40 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | Aug 21, 2019 | Buy | $24.87 | 1,635 | 40,660 | 2,847,575 | Nov 29, 2019, 01:07 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | Aug 21, 2019 | Buy | $24.87 | 420 | 10,445 | 2,845,940 | Nov 29, 2019, 01:07 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | Aug 20, 2019 | Buy | $25.69 | 2,310 | 59,344 | 2,845,520 | Nov 29, 2019, 01:07 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | Aug 20, 2019 | Buy | $25.69 | 600 | 15,414 | 2,843,210 | Nov 29, 2019, 01:07 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | Aug 16, 2019 | Buy | $26.37 | 700 | 18,460 | 2,840,510 | Nov 29, 2019, 12:59 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | Aug 19, 2019 | Buy | $26.50 | 2,100 | 55,640 | 2,842,610 | Nov 29, 2019, 12:59 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | May 10, 2019 | Buy | $27.05 | 80 | 2,164 | 2,839,810 | Nov 29, 2019, 12:52 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | May 10, 2019 | Buy | $27.58 | 4,170 | 115,009 | 2,839,730 | Nov 29, 2019, 12:52 PM |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | May 10, 2019 | Buy | $26.41 | 4,350 | 114,883 | 2,835,560 | Nov 29, 2019, 12:52 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | Aug 20, 2019 | Buy | $25.69 | 600 | 15,414 | 2,830,196 | Aug 21, 2019, 04:54 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | Aug 21, 2019 | Buy | $24.87 | 1,635 | 40,660 | 2,834,561 | Aug 21, 2019, 04:54 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | Aug 21, 2019 | Buy | $24.87 | 420 | 10,445 | 2,832,926 | Aug 21, 2019, 04:54 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | Aug 20, 2019 | Buy | $25.69 | 2,310 | 59,344 | 2,832,506 | Aug 21, 2019, 04:54 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | Aug 19, 2019 | Buy | $26.50 | 2,100 | 55,640 | 2,829,596 | Aug 19, 2019, 05:10 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | Aug 16, 2019 | Buy | $26.37 | 700 | 18,460 | 2,827,496 | Aug 19, 2019, 05:10 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | May 10, 2019 | Buy | $27.05 | 80 | 2,164 | 2,826,796 | Jun 14, 2019, 12:48 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | May 10, 2019 | Buy | $27.58 | 4,170 | 115,009 | 2,826,716 | Jun 14, 2019, 12:48 PM |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | May 10, 2019 | Buy | $26.41 | 4,350 | 114,883 | 2,822,546 | Jun 14, 2019, 12:48 PM |
| PFIZER INC | 10% Owner | May 13, 2019 | Buy | $17.00 | 50,000 | 850,000 | 3,249,973 | May 14, 2019, 07:34 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Monohon Ted | Chief Accounting Officer & VP | 12/05/2022 | 1,181 |
| Monohon Ted | Chief Accounting Officer & VP | 09/06/2022 | 2,493 |
| Monohon Ted | Chief Accounting Officer & VP | 06/06/2022 | 4,770 |
| Holsinger Leslie | EVP, Preclinical Development | 06/06/2022 | 31,231 |
| McDowell Caryn Gordon | Chief Legal & Adm. Officer | 06/06/2022 | 19,183 |
| McDowell Caryn Gordon | Chief Legal & Adm. Officer | 06/06/2022 | 30,923 |
| Lynch Casey | Chief Executive Officer | 11/18/2021 | 27,600 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 11/16/2021 | 66,900 |
| Dominy Stephen S. | Chief Scientific Officer | 11/12/2021 | 10,987 |
| McLoughlin Margaret | Director | 10/08/2021 | 17,000 |
| McLoughlin Margaret | Director | 10/08/2021 | 88,930 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 10/05/2021 | 272,221 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 10/05/2021 | 488,856 |
| McLoughlin Margaret | Director | 08/16/2021 | 102,000 |
| McLoughlin Margaret | Director | 08/16/2021 | 572,644 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 08/17/2021 | 66,900 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 08/16/2021 | 49,060 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 08/16/2021 | 2,096,779 |
| Detke Michael J. | Chief Medical Officer | 08/10/2021 | 22,300 |
| Detke Michael J. | Chief Medical Officer | 08/10/2021 | 1,000,000 |
| Detke Michael J. | Chief Medical Officer | 07/07/2021 | 38,802 |
| Detke Michael J. | Chief Medical Officer | 07/06/2021 | 28,098 |
| Detke Michael J. | Chief Medical Officer | 07/06/2021 | 2,187,623 |
| Detke Michael J. | Chief Medical Officer | 07/07/2021 | 960,549 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 06/30/2021 | 66,900 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 06/28/2021 | 44,600 |
| LOWE CHRISTOPHER P. | COO & Chief Financial Officer | 06/28/2021 | 1,083,074 |
| McLoughlin Margaret | Director | 06/28/2021 | 30,332 |
| Lamond David | Director | 03/24/2021 | 1,688,500 |
| Lynch Casey | Chief Executive Officer | 03/22/2021 | 1,067,611 |
| Lamond David | Director | 03/04/2021 | 1,767,057 |
| Lynch Casey | Chief Executive Officer | 02/03/2021 | 860,530 |
| Lynch Casey | Chief Executive Officer | 02/02/2021 | 724,102 |
| Lynch Casey | Chief Executive Officer | 02/01/2021 | 724,968 |
| Holsinger Leslie | Executive Vice President | 12/14/2020 | 10,800 |
| Holsinger Leslie | Executive Vice President | 12/14/2020 | 1,232,528 |
| Holsinger Leslie | Executive Vice President | 12/10/2020 | 945 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | 06/12/2020 | 107,506 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | 06/11/2020 | 292,512 |
| Lamond David | Director | 06/04/2020 | 2,125,795 |
| PFIZER INC | 10% Owner | 06/03/2020 | 14,866,600 |
| Detke Michael J. | Chief Medical Officer | 05/27/2020 | 38,109 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | 05/22/2020 | 116,552 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | 05/21/2020 | 29,016 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | 05/20/2020 | 352,605 |
| Lamond David | Director | 05/19/2020 | 2,204,683 |
| Lamond David | Director | 05/15/2020 | 266,569 |
| Detke Michael J. | Chief Medical Officer | 04/02/2020 | 38,109 |
| YOUNG KEVIN | Director | 05/13/2019 | 510,000 |
| RYAN UNA S | Director | 05/13/2019 | 48,875 |
| McLoughlin Margaret | Director | 05/13/2019 | 9,350 |
| Lamond David | Director | 02/10/2020 | 1,500,000 |
| Detke Michael J. | Chief Medical Officer | 02/07/2020 | 119,066 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% Owne | 01/29/2020 | 235,553 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 08/21/2019 | 40,660 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 08/21/2019 | 10,445 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 08/20/2019 | 59,344 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 08/20/2019 | 15,414 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 08/16/2019 | 18,460 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 08/19/2019 | 55,640 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 05/10/2019 | 2,164 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 05/10/2019 | 115,009 |
| EPIQ Capital Group, LLC | IA/Managing Member of 10% owne | 05/10/2019 | 114,883 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 08/20/2019 | 15,414 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 08/21/2019 | 40,660 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 08/21/2019 | 10,445 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 08/20/2019 | 59,344 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 08/19/2019 | 55,640 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 08/16/2019 | 18,460 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 05/10/2019 | 2,164 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 05/10/2019 | 115,009 |
| EPIQ Capital Group, LLC | IA/Managing Member 10% owner | 05/10/2019 | 114,883 |
| PFIZER INC | 10% Owner | 05/13/2019 | 850,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2022
8.71%
2Q
12/31/2021
10.23%
3Q
09/30/2021
10.53%
4Q
06/30/2021
10.78%
5Q
03/31/2021
10.84%
6Q
12/31/2020
12.28%
7Q
09/30/2020
12.70%
8Q
06/30/2020
13.54%
9Q
03/31/2020
15.91%
10Q
Load More